Benzocaine/tetracaine - Cetylite Industries

Drug Profile

Benzocaine/tetracaine - Cetylite Industries

Alternative Names: Benzocaine/tetracaine; CTY-5339; CTY-5339 Anesthetic Spray; CTY-5339-A; Tetracaine/benzocaine

Latest Information Update: 02 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cetylite
  • Class Anaesthetics; Local anaesthetics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Anaesthesia

Most Recent Events

  • 01 Jul 2017 Cetylite initiates enrolment in a phase II trial for Anesthesia (In volunteers) in USA (NCT03233737)
  • 07 Jun 2017 Cetylite completes a phase II trial in Anesthesia (In volunteers) in USA (NCT02908620)
  • 03 Oct 2016 Preclinical trials in Anaesthesia in USA (Topical) (NCT02908620) before October 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top